References
- Arromede E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. (2002) Epidemiology of gout: is the incidence rising? J. Rheumatol. 29, 2403-2406
- Berry CE, Hare JM. (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J. Physiol. 555, 589-606 https://doi.org/10.1113/jphysiol.2003.055913
- Bowman WC, Rand MJ. (1980) Textbook of pharmacology, 2nd ed., pp.243-244. Blackwell, Sydney
- Burke A, Smyth E, FitzGerald GA. (2006) Analgesic . antipyretic agents; pharmacotherapy of gout. In: The pharmacological basis of therapeutics, edited by Brunton LL, Lazo JS, Parker KL. 11th ed., p. 706- 710, McGraw.Hill Medical Publishing Division, New York
- Chang WS, Lee YJ, Lu FJ, Chaing HC. (1993) Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res. 13, 2165-2170
- Costantino L, Albasini A, Rastelli G, Benvenuti S. (1992) Activity of polyphenolic crude extracts as scavengers of superoxide radicals and inhibitors of xanthine oxidase. Planta Med. 58, 342-344 https://doi.org/10.1055/s-2006-961481
- Emmerson BT. (1996) The management of gout. N. Engl. J. Med. 334, 445-451 https://doi.org/10.1056/NEJM199602153340707
- Emmerson BT. (1998). Hyperlipidaemia in hyperuricaemia and gout. Ann. Rheum. Dis. 57, 509-510
- Fukunari A, Okamoto K, Nishino T, Eger BT, Pai EF, Kamezawa M, Yamada I, Kato N. (2004) Y-700 [1- [3-cyano-4-(2,2-dimethylpropoxy)phenyl]-1H pyrazole- 4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion. J. Pharmacol. Exp. Ther. 311, 519-528 https://doi.org/10.1124/jpet.104.070433
- Gonzalez AG, Bazzocchi IL, Moujir L, Ravelo AG, Correa MD, Gupta AP. (1995) Xanthineoxidase inhibitory activity of some Panamanian plants from Celastraceae and Lamiaceae. J. Ethnopharmacol. 46, 25-29 https://doi.org/10.1016/0378-8741(95)01225-3
- Hall IH, Scoville JP, Reynolds DJ, Simlot R, Duncan P. (1990) Substituted cyclic imides as potential antigout agents. Life Sci. 46, 1923-1927 https://doi.org/10.1016/0024-3205(90)90507-N
- Halliwell B, Gutteridge JMC. (2001) Free radicals in biology and medicine, 3rd ed. pp. 28-30, Oxford University press, Oxford
- Iio M, Moriyama A, Matsumoto Y, Takaki N, Fukumoto M. (1985) Inhibition of Xanthine oxidase by Flavonoids. J. Agric. Biol. Chem. 49, 2173-2176
- Kirthikar KR, Basu BD. (1987) Indian Medicnal Plants, 2nd ed., pp. 1151-1154. International Book Distributors, Dehradun
- Kong LD, Cai Y, Huang WW, Cheng CHK, Tan RX. (2000) Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J. Ethnopharmacol. 73, 199-207 https://doi.org/10.1016/S0378-8741(00)00305-6
- Kong LD, Yang C, Ge F, Wang HD, Guo YS. (2004) A Chinese herbal medicine Ermia wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J. Ethnopharmacol. 93, 325-330 https://doi.org/10.1016/j.jep.2004.04.008
- Kramer HM, Curhan G. (2002) The association between gout and nephrolithiasis. Am. J. Kidney Dis. 40, 37-42
- Kumar A, Edward N, White MI, Johnston PW, Catto GR. (1996) Allopurinol, erythema multiforme and renal insufficiency. Br. Med. J. 312, 173-174
- Lewis HB, Doisy EA. (1918) Studies in uric acid metabolism. I. The influence of high protein diets on the endogenous uric acid elimination. J. Biol. Chem. 36, 1-7
- Lin KC, Lin HY, Chou P. (2000). The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J. Rheumatol. 27, 1501.1505
- Liote F. (2003). Hyperuricaemia and gout. Curr. Rhemumatol. Rep. 5, 227-234 https://doi.org/10.1007/s11926-003-0072-y
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951) Protein measurement with protein phenol reagent. J. Biol. Chem. 193, 265-275
- Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ. (2001) Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38, 1101-1106 https://doi.org/10.1161/hy1101.092839
- Nakagawa T, Mazzali M, Kang D, Sanchez-Lozada LG, Herrera-Acosta J, Johnson RJ. (2006) Uric acid . a uremic toxin? Blood Purif. 24, 67-70 https://doi.org/10.1159/000089440
- Owen PL, Johns T. (1999). Xanthine oxidase inhibitory activity of northeastern North American plant remedies used for gout. J. Ethnopharmacol. 64, 149-160 https://doi.org/10.1016/S0378-8741(98)00119-6
- Rang HP, Dale MM, Ritter JM. (2001) Pharmacology, 4th ed., pp.239, Churchill Livingstone, London
- Stavric B, Clayman S, Gradd REA, Hebert D. (1975) Some in vivo effects in the rat induced by chlorprothixene and potassium oxonate. Pharmacol. Res. Commun. 7, 117-124 https://doi.org/10.1016/S0031-6989(75)80015-4
- Theoduloz C, Pacheco P, Schemeda-Hirschmann G. (1991) Xanthine oxidase inhibitory activity of Chilean Myrtaceae. J. Ethnopharmacol. 33, 253-255 https://doi.org/10.1016/0378-8741(91)90085-R
- Umamaheswari M, Chatterjee TK. (2008). In vitro antioxidant activities of the fractions of Coccinia grandis L. leaf extract. Afr. J. Trad. CAM. 5, 61-73
- Venkateswaran S, Pari L. (2003) Effect of Coccinia indica leaves on antioxidant status in streptozotocininduced diabetic rats. J. Ethnopharmacol. 84, 163-168 https://doi.org/10.1016/S0378-8741(02)00294-5
- Wallach SL. (1998) The side effects of allopurinol. Hosp. Pract. 33, 22
- Wang Y, Zhu JX, Kong LD, Yang C, Cheng CH, Zhang X. (2004) Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/ oxidase activities in oxonate-treated mice. Basic Clin. Pharmacol. Toxicol. 94, 232-237
- Wasantwisut E, Viriyapanich T. (2003) Ivy gourd (Coccinia grandis Voigt, Coccinia cardifolia, Coccinia indica) in human nutrition and traditional applications. In: Plants in Human Health and Nutrition Policy: World Reviews of Nutrition and Dietics, edited by Simopoulous AP, Gopalan C, p. 60-66, Karger, Basel